Possibility
Explore our work: what we do, how we do it, and the value we create for our clients.
Impact
Culture
Possibility
Explore our work: what we do, how we do it, and the value we create for our clients.
Industries
Consumer and manufacturing
Defence and security
Energy and utilities
Financial services
Government and public sector
Health
Life sciences
Transport
Services
Set actionable strategy
Build products, services, and experiences
Reimagine AI, digital, and data
Improve organisational performance
Deliver complex programmes
Empower your people
Global Shifts
Empowered consumers
Healthier humans
Future organisations
Safer societies
Regenerative futures
Impact
Culture

Health

Showing 331-340 of 342 results
Sort by:
Client Story

AstraZeneca

Transforming IT to reduce costs by a third
Monica Healthcare
Client Story

Monica Healthcare

Saving the lives of thousands of babies each year
Monica Healthcare
In the media

Many STP areas are yet to find a joint understanding

PA’s John Rooke discusses the views of clinical commissioning group leaders in regard to their sustainability and transformation plans.
Health Service Journal
25 October 2016
Insight

Brexit: the eye of the storm

The UK life sciences sector will undoubtedly be affected by the Brexit after the decision that Article 50 will be triggered by the end of March 2017; and it needs to start preparing now for the uncertainties ahead.
Client Story

Sphere Medical

Helping diagnose and monitor patients in critical care
In the media

Building a better self-injection solution

Pharmaceutical Technology
02 June 2016
In the media

CCG barometer comment: Ever closer union?

Health Service Journal
25 April 2016
Insight

Place-based commissioning – Radical thinking required

Integrated, outcomes-focused care and the creation of Accountable Care Systems (ACSs)
Insight

Securing transformational change in the NHS

If the NHS is to survive in a post-austerity era, transformational change is essential. Without it, the NHS will be unable to meet the needs of an ageing population or afford the rising cost of treatment, and ultimately faces oblivion. However, achieving transformational change is easier said than done.
Insight

Pharma and big data – the commercial opportunity

Big data can unlock the potential of existing medicines. By analysing data about their existing treatments, pharma companies have a real opportunity to prevent health problems that may be associated with the drugs.